Showing results (51-60 of 129) with videos related to

Sort By:
Pageof 13
Current Rheumatology Reports|October 1, 2016
Gout and Osteoarthritis: Associations, Pathophysiology, and Therapeutic ImplicationsChio Yokose, Meng Chen, Adey Berhanu, et al.
Bulletin of the NYU Hospital for Joint Diseases|December 17, 2009
Drug-induced myopathiesAdam Mor, Hal J Mitnick, Michael H Pillinger, et al.
Arthritis Research & Therapy|July 25, 2023
Interleukin-1β inhibitors for the management of acute gout flares: a systematic literature reviewNaomi Schlesinger, Michael H Pillinger, Lee S Simon, et al.
Rheumatic Diseases Clinics of North America|March 30, 2011
Drugs causing muscle diseaseAdam Mor, Robert L Wortmann, Hal J Mitnick, et al.
Seminars in Arthritis and Rheumatism|October 23, 2016
Pegloticase failure and a possible solution: Immunosuppression to prevent intolerance and inefficacy in patients with goutAdey A Berhanu, Svetlana Krasnokutsky, Robert T Keenan, et al.
Annals of Internal Medicine|May 16, 2007
Narrative review: the pathophysiology of fibromyalgiaAryeh M Abeles, Michael H Pillinger, Bruce M Solitar, et al.
The American Journal of Medicine|July 1, 2008
Update on fibromyalgia therapyMicha Abeles, Bruce M Solitar, Michael H Pillinger, et al.
Current Opinion in Rheumatology|September 6, 2014
The causes of drug-induced muscle toxicityJonathan D Jones, Hannah L Kirsch, Robert L Wortmann, et al.
The Journal of Rheumatology|June 17, 2019
Dissociation Between Clinical Benefit and Persistent Urate Lowering in Patients with Chronic Refractory Gout Treated with PegloticaseMichael H Pillinger, Theodore R Fields, Anthony E Yeo, et al.
Clinical Rheumatology|August 8, 2014
Co-occurrence of Kikuchi-Fujimoto's disease and Still's disease: case report and review of previously reported casesKaren A Toribio, Hideko Kamino, Stephanie Hu, et al.
Pageof 13